MY140382A - Lactate containing pharmaceutical composition and uses thereof - Google Patents

Lactate containing pharmaceutical composition and uses thereof

Info

Publication number: MY140382A
Authority: MY; Malaysia
Prior art keywords: pharmaceutical composition; per liter; containing pharmaceutical; lactic acid; lactate
Prior art date: 2003-05-01

Application number

MYPI20040998A

Other languages

English (en)

Inventor

Professer Xavier M Leverve

Iqbal Dr Mustafa

Original Assignee

Innogene Kalbiotech Pte Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-01

Filing date

2004-03-22

Publication date

2009-12-31

2004-03-22 Application filed by Innogene Kalbiotech Pte Ltd filed Critical Innogene Kalbiotech Pte Ltd

2009-12-31 Publication of MY140382A publication Critical patent/MY140382A/en

Links

JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 6
235000014655 lactic acid Nutrition 0.000 abstract 3
239000004310 lactic acid Substances 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Inorganic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Surgery (AREA)
Child & Adolescent Psychology (AREA)
Oncology (AREA)

MYPI20040998A 2003-05-01 2004-03-22 Lactate containing pharmaceutical composition and uses thereof MY140382A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ID20030213		2003-05-01

Publications (1)

Publication Number	Publication Date
MY140382A true MY140382A (en)	2009-12-31

Family

ID=33397627

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI20040998A MY140382A (en)	2003-05-01	2004-03-22	Lactate containing pharmaceutical composition and uses thereof

Country Status (30)

Country	Link
US (1)	US20080125488A1 (pl)
EP (2)	EP1617834B1 (pl)
JP (1)	JP5037937B2 (pl)
KR (1)	KR101076059B1 (pl)
CN (1)	CN1777416B (pl)
AR (1)	AR043670A1 (pl)
AT (1)	ATE340568T1 (pl)
AU (1)	AU2004233904B2 (pl)
BR (1)	BRPI0409867A (pl)
CA (1)	CA2523740C (pl)
CY (1)	CY1105880T1 (pl)
DE (1)	DE602004002585T2 (pl)
DK (1)	DK1617834T3 (pl)
EA (2)	EA013846B1 (pl)
ES (1)	ES2274438T3 (pl)
IL (1)	IL171721A (pl)
MA (1)	MA27845A1 (pl)
MX (1)	MXPA05011532A (pl)
MY (1)	MY140382A (pl)
NO (1)	NO20055652L (pl)
NZ (1)	NZ543201A (pl)
PL (1)	PL1617834T3 (pl)
PT (1)	PT1617834E (pl)
SG (1)	SG160217A1 (pl)
SI (1)	SI1617834T1 (pl)
TN (1)	TNSN05275A1 (pl)
TW (1)	TWI290045B (pl)
UA (1)	UA86937C2 (pl)
WO (1)	WO2004096204A1 (pl)
ZA (1)	ZA200509684B (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2007371A4 (en) *	2006-04-03	2009-07-22	Innogene Kalbiotech Pte Ltd	LACTAT AND CALCIUM-CONTAINED PHARMACEUTICAL COMPOSITION AND ITS USES
PL2142186T3 (pl)	2007-03-30	2014-09-30	Laccure Ab	Stosowanie oligomerów kwasu mlekowego w leczeniu zaburzeń ginekologicznych
WO2010111650A2 (en) *	2009-03-26	2010-09-30	Pulmatrix, Inc.	Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
AU2010229668C1 (en)	2009-03-26	2016-09-15	Pulmatrix Operating Co., Inc.	Dry powder formulations and methods for treating pulmonary diseases
WO2012030664A1 (en)	2010-08-30	2012-03-08	Pulmatrix, Inc.	Dry powder formulations and methods for treating pulmonary diseases
US20130164338A1 (en)	2010-08-30	2013-06-27	Pulmatrix, Inc.	Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
WO2012044736A1 (en)	2010-09-29	2012-04-05	Pulmatrix, Inc.	Monovalent metal cation dry powders for inhalation
PT3470057T (pt)	2010-09-29	2021-12-03	Pulmatrix Operating Co Inc	Pós secos catiónicos compreendendo sais de magnésio
ES2396650B2 (es) *	2011-07-21	2013-07-16	Universidad Complutense De Madrid	Uso de una composición en la elaboración de una solución de diálisis para el tratamiento de las enfermedades cerebrovasculares mediante diálisis peritoneal.
CA2865972C (en)	2012-02-29	2022-01-04	Pulmatrix, Inc.	Inhalable dry powders
WO2013169939A2 (en)	2012-05-08	2013-11-14	Aeromics, Llc	New methods
US10660869B2 (en) *	2012-08-01	2020-05-26	Purac Biochem B.V.	Lactate powder and method for the preparation thereof
US9500657B2 (en)	2012-10-25	2016-11-22	Run Them Sweet Llc	Formulations containing labels for medical diagnostics
US9232815B2 (en)	2012-10-25	2016-01-12	Run Them Sweet, LLC	Blood lactate range targets and nutritional formulations and protocols to support patients
US9897609B2 (en)	2012-10-25	2018-02-20	Run Them Sweet, LLC	Systems and apparatus to estimate nutritional needs of human and other patients and to support such nutritional needs
EP2754356A1 (en)	2013-01-15	2014-07-16	Purac Biochem N.V.	Improved nisin production process
EP2769630B1 (en)	2013-02-26	2016-04-27	Purac Biochem N.V.	Improved nisin production process
WO2014165303A1 (en)	2013-04-01	2014-10-09	Pulmatrix, Inc.	Tiotropium dry powders
CN112402434A (zh)	2013-11-06	2021-02-26	埃罗米克斯公司	新配方
WO2015182815A1 (ko) *	2014-05-26	2015-12-03	한국생명공학연구원	Ndrg3 발현 또는 활성 촉진제를 유효성분으로 함유하는 허혈성 질환 예방 및 치료용 약학적 조성물
CA3026631C (en)	2016-07-07	2024-03-26	Dsm Ip Assets B.V.	Process for obtaining a rapeseed protein isolate and protein isolate thereby obtained
US10124021B2 (en) *	2016-12-23	2018-11-13	Andrew L. Gostine	Intravenous fluid
US20200246127A1 (en) *	2019-02-06	2020-08-06	Lumen Therapeutics, Llc	Biologically modified vascular grafts for improved bypass surgery outcomes
EP4093507A4 (en) *	2020-01-24	2024-02-28	Barkey, Daniel, Q.	COMPOSITIONS AND METHODS FOR WEIGHT LOSS
US20250041214A1 (en) *	2021-12-16	2025-02-06	Alveolus Bio, Inc.	Inhalable or ingestible lactic acid compositions for the treatment of chronic lung disease
CN116531358A (zh) *	2023-06-06	2023-08-04	中国医科大学附属第一医院	含乳酸盐缓冲体系在制备心力衰竭治疗药物中的应用
EP4502147A1 (en)	2023-07-31	2025-02-05	M2Rlab SL	Method for the polarization of cells to a new m2 phenotype and uses of said m2-polarized cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6776887A (en) *	1985-12-18	1987-07-15	Veech, R.L.	Fluid therapy with l-lactate and/or pyruvate anions
EP0441119A3 (en) *	1990-01-09	1992-10-14	Richard D. Levere	The use of l-arginine in the treatment of hypertension and other vascular disorders
US5248507A (en) *	1991-05-31	1993-09-28	Board Of Regents, The University Of Texas System	Hypertonic isochloremic formulation for circulatory shock
JPH05255092A (ja) *	1992-03-17	1993-10-05	Kyowa Hakko Kogyo Co Ltd	腸管洗浄用組成物
DK0701455T3 (da) *	1993-06-04	2001-06-18	Biotime Inc	Plasmalignende opløsning
US6306828B1 (en) *	1995-04-06	2001-10-23	Baxter International, Inc.	Enantiomerically-enhanced nutritional energy substrates
JPH0940554A (ja) *	1995-08-03	1997-02-10	Nissho Corp	グルタミンを含む輸液及びその製造方法
WO1998008500A1 (en) *	1996-08-26	1998-03-05	Board Of Regents, The University Of Texas System	Hypertonic arginine compositions and methods
US6436444B1 (en) *	1997-09-26	2002-08-20	Ecolab Inc.	Acidic aqueous chlorite teat dip providing shelf life sanitizing capacity and tissue protection
CN1068778C (zh) *	1998-05-15	2001-07-25	赵超英	救治用的药物组合物及其制备方法
RU2136293C1 (ru) *	1998-08-04	1999-09-10	Открытое акционерное общество "Биохимик"	Способ получения заменителя плазмы крови

2004
- 2004-03-22 DE DE602004002585T patent/DE602004002585T2/de not_active Expired - Lifetime
- 2004-03-22 EA EA200801073A patent/EA013846B1/ru not_active IP Right Cessation
- 2004-03-22 DK DK04722501T patent/DK1617834T3/da active
- 2004-03-22 SG SG200717319-8A patent/SG160217A1/en unknown
- 2004-03-22 AT AT04722501T patent/ATE340568T1/de active
- 2004-03-22 WO PCT/SG2004/000066 patent/WO2004096204A1/en not_active Ceased
- 2004-03-22 MX MXPA05011532A patent/MXPA05011532A/es active IP Right Grant
- 2004-03-22 AR ARP040100933A patent/AR043670A1/es not_active Application Discontinuation
- 2004-03-22 MY MYPI20040998A patent/MY140382A/en unknown
- 2004-03-22 PL PL04722501T patent/PL1617834T3/pl unknown
- 2004-03-22 US US10/555,196 patent/US20080125488A1/en not_active Abandoned
- 2004-03-22 PT PT04722501T patent/PT1617834E/pt unknown
- 2004-03-22 CA CA2523740A patent/CA2523740C/en not_active Expired - Fee Related
- 2004-03-22 JP JP2006508059A patent/JP5037937B2/ja not_active Expired - Fee Related
- 2004-03-22 EP EP04722501A patent/EP1617834B1/en not_active Expired - Lifetime
- 2004-03-22 NZ NZ543201A patent/NZ543201A/en not_active IP Right Cessation
- 2004-03-22 ES ES04722501T patent/ES2274438T3/es not_active Expired - Lifetime
- 2004-03-22 UA UAA200511417A patent/UA86937C2/ru unknown
- 2004-03-22 SI SI200430136T patent/SI1617834T1/sl unknown
- 2004-03-22 AU AU2004233904A patent/AU2004233904B2/en not_active Ceased
- 2004-03-22 BR BRPI0409867-6A patent/BRPI0409867A/pt not_active IP Right Cessation
- 2004-03-22 EP EP06121128A patent/EP1759695A1/en not_active Withdrawn
- 2004-03-22 CN CN2004800110612A patent/CN1777416B/zh not_active Expired - Fee Related
- 2004-03-22 EA EA200501675A patent/EA010948B1/ru not_active IP Right Cessation
- 2004-03-23 TW TW093107705A patent/TWI290045B/zh not_active IP Right Cessation
2005
- 2005-10-24 TN TNP2005000275A patent/TNSN05275A1/en unknown
- 2005-11-01 IL IL171721A patent/IL171721A/en active IP Right Grant
- 2005-11-01 KR KR1020057020706A patent/KR101076059B1/ko not_active Expired - Fee Related
- 2005-11-30 NO NO20055652A patent/NO20055652L/no not_active Application Discontinuation
- 2005-11-30 ZA ZA200509684A patent/ZA200509684B/en unknown
- 2005-12-01 MA MA28632A patent/MA27845A1/fr unknown
2006
- 2006-12-21 CY CY20061101847T patent/CY1105880T1/el unknown

Also Published As

Publication number	Publication date
EA013846B1 (ru)	2010-08-30
WO2004096204A1 (en)	2004-11-11
PT1617834E (pt)	2007-01-31
ZA200509684B (en)	2007-03-28
ES2274438T3 (es)	2007-05-16
SG160217A1 (en)	2010-04-29
NO20055652L (no)	2006-02-01
JP2006525324A (ja)	2006-11-09
JP5037937B2 (ja)	2012-10-03
KR20050119701A (ko)	2005-12-21
ATE340568T1 (de)	2006-10-15
EP1617834B1 (en)	2006-09-27
CA2523740A1 (en)	2004-11-11
IL171721A (en)	2012-05-31
DE602004002585D1 (de)	2006-11-09
KR101076059B1 (ko)	2011-10-21
CY1105880T1 (el)	2011-02-02
EA200501675A1 (ru)	2006-06-30
CN1777416A (zh)	2006-05-24
TW200423923A (en)	2004-11-16
UA86937C2 (ru)	2009-06-10
EP1759695A1 (en)	2007-03-07
AR043670A1 (es)	2005-08-03
EA200801073A1 (ru)	2008-08-29
BRPI0409867A (pt)	2006-05-16
EA010948B1 (ru)	2008-12-30
MA27845A1 (fr)	2006-04-03
HK1085942A1 (en)	2006-09-08
AU2004233904A1 (en)	2004-11-11
DE602004002585T2 (de)	2007-10-25
EP1617834A1 (en)	2006-01-25
SI1617834T1 (sl)	2007-02-28
NO20055652D0 (no)	2005-11-30
TWI290045B (en)	2007-11-21
TNSN05275A1 (en)	2007-07-10
AU2004233904B2 (en)	2009-11-12
PL1617834T3 (pl)	2007-02-28
NZ543201A (en)	2007-05-31
CN1777416B (zh)	2012-11-07
CA2523740C (en)	2012-05-15
DK1617834T3 (da)	2007-02-05
MXPA05011532A (es)	2006-05-31
US20080125488A1 (en)	2008-05-29

Publication	Publication Date	Title
SG160217A1 (en)	2010-04-29	Lactate containing pharmaceutical composition and uses thereof
SG131109A1 (en)	2007-04-26	Muteins of tear lipocalin
MY143771A (en)	2011-07-15	Low ph aerated products
TW200514772A (en)	2005-05-01	Novel tetrahydropyridine derivatives
ZA200501128B (en)	2006-10-25	Biphasic composition induced by polydextrose
AU8057401A (en)	2002-02-05	Antimicrobial composition useful for the treatment of bovine mastitis
ATE408022T1 (de)	2008-09-15	Ermittlung des patientenbezogenen kariesrisikos
DE60331344D1 (en)	2010-04-01	Biguanidderivate
TW200603746A (en)	2006-02-01	Iron sulfate based phosphate adsorbent
CO6300914A2 (es)	2011-07-21	Bebida que contiene amino acidos y calcio
WO2004039326A3 (en)	2004-08-12	Propofol with cysteine
GEP20135735B (en)	2013-01-25	Pharmaceutical compositions of rosuvastatin calcium
WO2003086335A8 (en)	2003-12-24	Hair care composition for restoring the elasticity of hair
CA2431515A1 (en)	2002-08-01	Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof
MY164917A (en)	2018-02-15	Lactate containing pharmaceutical composition and uses thereof
MY144306A (en)	2011-08-29	Aquoues solution of olanexidine, method of preparing the aqueous solution, and disinfectant
AU2003267359A1 (en)	2004-04-19	Sweet containing calcium
IL154007A0 (en)	2003-07-31	Soluble fertilizer compositions comprising calcium and/or magnesium phosphates
MY138502A (en)	2009-06-30	Novel alkansulfonamides as endothelin antagonists
EA200400650A1 (ru)	2004-10-28	Трансдермальная фармацевтическая композиция, содержащая аспирин, для лечения кальцификации
WO2004022657A3 (de)	2004-09-02	Verstärkung der resorption von substanzen über die haut und schleimhaut
WO2004071381A3 (de)	2004-11-18	Arzneimittel enthaltend substituierte 2-aryl-aminoessigsäure-verbindungen und/oder substituierte 2-heteroaryl-aminoessigsäure-verbindungen
TH89001A (th)	2008-03-20	ส่วนประกอบทางเภสัชกรรมที่มีแลคเตตและการใช้ส่วนประกอบดังกล่าว
UA3507U (uk)	2004-11-15	Композиція квасу для окрошки
WO2005049066A3 (en)	2005-07-14	Use of dudulin2 for the treatment or prophylaxis of lung cancer